Summary
Increases in cytosolic free calcium concentration ([Ca2+]I) may play an important role in myocardial ischemic injury. An early effect of the rise in [Ca2+]I may be impaired postischemic contractile function if the ischemic myocardium is reperfused during the reversible phase of ischemic injury; furthermore, if the rise in [Ca2+]I is prolonged, a cascade of events may be initiated which ultimately results in lethal injury. With the development of methods for measuring [Ca2+]I, it has become possible to evaluate directly the role of increased [Ca2+]I in myocardial ischemic injury. Although it has been possible to show that inhibition of the transport processes which contribute to the early rise in [Ca2+]I attenuates stunning and the rise in [Ca2+]I concurrently, if increased [Ca2+]I plays an important role in ischemic injury, then it should be possible to show that interventions which alter the timecourse of ischemic injury also alter the timecourse of the rise in [Ca2+]I in a parallel manner. Recently, considerable effort has been expended to investigate the mechanisms underlying the preconditioning phenomenon, whereby repetitive brief periods of ischemia prior to a sustained period of ischemia protects the myocardium from injury during the sustained period of ischemia, and this has stimulated additional work to understand the possible involvement of adenosine as a mediator of preconditioning as well as to understand the protective effects of adenosine. Measurements of [Ca2+]I using 19F NMR of 5FBAPTA-loaded hearts have shown that preconditioning attenuates the rise in [Ca2+]I during 30 min of ischemia and reduces stunning during reflow. Adenosine pretreatment mimics the effects of preconditioning on the rise in [Ca2+]I and on stunning, but adenosine receptor antagonists do not eliminate the protective effects of preconditioning, although some adenosine antagonists also block hexose transport and under these conditions, the ability of preconditioning to attenuate the rise in [Ca2+]I is abolished and there is a corresponding loss of the protective effect of preconditioning on stunning. Although it has been suggested that the beneficial effect of preconditioning on infarct size can be eliminated by pretreatment with glibenclamide, in the isolated rat heart glibenclamide does not affect the attenuation of the rise in [Ca2+]I induced by preconditioning and does not affect stunning. All of these studies show a consistent relationship between the magnitude of the rise in [Ca2+]I during ischemia and the degree of stunning during reperfusion. The data suggest that increased [Ca2+]I plays a very important role in myocardial ischemic injury.
Similar content being viewed by others
References
Cave AC, Collis CS, Downey JM, Hearse DJ (1993) Improved functional recovery by ischaemic preconditioning is not mediated by adenosine in the globally ischaemic isolated rat heart. Cardiovasc Res 27:663–668
Cohen MV, Liu GS, Downey JM (1991) Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits. Circulation 84:341–349
Cole WC, McPherson CD, Sontag D (1991) ATP-regulated K+ channels protect the myocardium against ischemia/reperfusion damage. Circ Res 69:571–581
Escande D (1989) The pharmacology of ATP-sensitive K+ channels in the heart. Pfluegers Arch 414 (Suppl 1):S93-S98
Farber JL (1990) The role of calcium ions in toxic cell injury. Environ Health Perspec 84:107–111
Fralix TA, Murphy E, London RE, Steenbergen C (1993) Protective effects of adenosine in the perfused rat heart: Changes in metabolism and intracellular ion homeostasis. Am J Physiol 264:C986-C994
Fralix TA, Steenbergen C, London RE, Murphy E (1993) Glibenclamide does not abolish the protective effect of preconditioning on stunning in the isolated perfused rat heart. Cardiovasc Res 27:630–637
Gasser RNA, Vaughan-Jones RD (1990) Mechanism of potassium efflux and action potential shortening during ischaemia in isolated mammalian cardiac muscle. J Physiol 431:713–741
Gross GJ, Auchampach JA (1992) Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 70:223–233
Grover GJ, Dzwonczyk S, Parham CS, Sleph PG (1990) The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogs. Cardiovasc Drugs Ther 4:465–474
Grover GJ, McCullough JR, Henry DE, Conder ML, Sleph PG (1989) Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide. J Pharmacol Exp Ther 251:98–104
Grover GJ, Newburger J, Sleph PG, Dzwonczyk S, Taylor SC, Ahmed SZ, Atwal KS (1991) Cardioprotective effects of the potassium channel opener cromakalim: stereoselectivity and effects on myocardial adenine nucleotides. J Pharmacol Exp Ther 257:156–162
Kirsch GE, Codina J, Birnbaumer L, Brown AM (1990) Coupling of ATP-sensitive K+ channels to A1 receptors by G proteins in rat ventricular myocytes. Am J Physiol 259:H820-H826
Koretsune Y, Marban E (1990) Mechanism of ischemic contracture in ferret hearts: relative roles of [Ca2+]I elevation and ATP depletion. Am J Physiol 258:H9-H16
Lasley RD, Anderson GM, Mentzer RM (Jr), (1993) Ischaemic and hypoxic preconditioning enhance postischaemic recovery of function in the rat heart. Cardiovasc Res 27:565–570
Lawson CS, Downey JM (1993) Preconditioning: state of the art myocardial protection. Cardiovasc Res 27:542–550
Li GC, Vasquez JA, Gallagher KP, Lucchesi BR (1990) Myocardial protection with preconditioning. Circulation 82:609–619
Liu GS, Thornton J, Van Winkle DM, Stanley AWH, Olsson REA, Downey JM (1991) Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circ Res 84:350–356
Liu Y, Downey JM (1992) Ischemic preconditioning protects against infarction in rat heart. Am J Physiol 263:H1107-H1112
Marban E (1991) Myocardial stunning and hibernation. The physiology behind the colloquialisms. Circulation 83:681–688
Murphy E, Fralix TA, London RE, Steenbergen C (1993) Effects of adenosine antagonists on hexose uptake and preconditioning in perfused rat heart. Am J Physiol (Cell Physiol), in press
Murphy E, Perlman M, London RE, Steenbergen C (1991) Amiloride delays the ischemia-induced rise in cytosolic free calcium. Circ Res 68:1250–1258
Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124–1136
Murry CE, Richard VJ, Reimer KA, Jennings RB (1990) Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 66:913–931
Nichols CG, Lederer WJ (1990) The regulation of ATP-sensitive K+ channel activity in intact and permeabilized rat ventricular myocytes. J Physiol 423:91–110
Nichols CG, Lederer WJ (1991) Adenosine triphosphate-sensitive potassium channels in the cardiovascular system. Am J Physiol 261:H1675-H1686
Nichols CG, Ripoll C, Lederer WJ (1991) ATP-sensitive potassium channel modulation of the guinea pig ventricular action potential and contraction. Circ Res 68:280–287
Schlüter KD, Schwartz P, Siegmund B, Piper HM (1991) Prevention of the oxygen paradox in hypoxic-reoxygenated hearts. Am J Physiol 261:H416-H423
Schott RJ, Rohmann S, Braun ER, Schaper W (1990) Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res 66:1133–1142
Siegmund B, Zude R, Piper HM (1992) Recovery of anoxic-reoxygenated cardiomyocytes from severe Ca2+ overload. Am J Physiol 263:H1262-H1269
Starke PE, Hoek JB, Farber JL (1986) Calcium-dependent and calcium-independent mechanisms of irreversible cell injury in cultured rat hepatocytes. J Biol Chem 261:3006–3012
Steenbergen C, Perlman ME, London RE, Murphy E (1993) Mechanisms of preconditioning: Ionic alterations. Circ Res 72:112–125
Thornton JD, Liu GS, Olsson RA, Downey JM (1992) Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction. Circulation 85:659–665
Toombs CF, McGee DS, Johnston WE, Vinten-Johansen J (1992) Myocardial protective effects of adenosine; infarct size reduction with pretreatment and continued receptor stimulation during ischemia. Circulation 86:986–994
Yellon DM, Alkhulaifi AM, Browne EE, Pugsley WB (1992) Ischaemic preconditioning limits infarct size in the rat heart. Cardiovasc Res 26:983–987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Steenbergen, C., Fralix, T.A. & Murphy, E. Role of increased cytosolic free calcium concentration in myocardial ischemic injury. Basic Res Cardiol 88, 456–470 (1993). https://doi.org/10.1007/BF00795412
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00795412